Publicaciones (39) Publicaciones de Juan Carlos Rodriguez-Manzaneque

2023

  1. ADAMTS-1 has nuclear localization in cells with epithelial origin and leads to decreased cell migration

    Experimental Cell Research, Vol. 433, Núm. 2

2022

  1. Gallic Acid: A Natural Phenolic Compound Exerting Antitumoral Activities in Colorectal Cancer via Interaction with G-Quadruplexes

    Cancers, Vol. 14, Núm. 11

  2. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 6

2021

  1. ADAMTS proteases and the tumor immune microenvironment: Lessons from substrates and pathologies

    Matrix Biology Plus, Vol. 9

  2. ADAMTS1 supports endothelial plasticity of glioblastoma cells with relevance for glioma progression

    Biomolecules, Vol. 11, Núm. 1, pp. 1-17

  3. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

  4. Metalloprotease ADAMTS-1 decreases cell migration and invasion modulating the spatiotemporal dynamics of Cdc42 activity

    Cellular Signalling, Vol. 77

2020

  1. Extracellular protease adamts1 is required at early stages of human uveal melanoma development by inducing stemness and endothelial-like features on tumor cells

    Cancers, Vol. 12, Núm. 4

  2. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

  3. Inhibition of ADAMTS1 Expression by Lentiviral CRISPR/Cas9 Gene Editing Technology

    Methods in Molecular Biology (Humana Press Inc.), pp. 13-24

2018

  1. ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response

    Scientific Reports, Vol. 8, Núm. 1

  2. Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294)

    Leukemia

  3. Evaluation of tumor vasculature using a syngeneic tumor model in wild-type and genetically modified mice

    Methods in Molecular Biology (Humana Press Inc.), pp. 179-192

  4. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

    Leukemia, Vol. 32, Núm. 3, pp. 633-644

2016

  1. Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis

    Oncotarget, Vol. 7, Núm. 23, pp. 34507-34519

2015

  1. ADAMTS proteases in vascular biology

    Matrix Biology, Vol. 44-46, pp. 38-45

  2. The Force at the Tip - Modelling Tension and Proliferation in Sprouting Angiogenesis

    PLoS Computational Biology, Vol. 11, Núm. 8

2014

  1. Carboxyl-modified single-wall carbon nanotubes improve bone tissue formation in vitro and repair in an in vivo rat model

    International journal of nanomedicine, Vol. 9, pp. 4277-4291

  2. Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1

    Oncotarget, Vol. 5, Núm. 12, pp. 4295-4304

2013

  1. Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2315-2324